The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute

Interventions designed to limit the spread of coronavirus disease 2019 (COVID-19) are having profound effects on the delivery of health care, but data showing the impact on oncology clinical trial enrollment, treatment, and monitoring are limited. We prospectively tracked relevant data from oncology...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolaney, Sara M, Lydon, Christine A, Li, Tianyu, Dai, Jiale, Standring, Andrea, Legor, Kristen A, Caparrotta, Caryn M, Schenker, Matthew P, Glazer, Daniel I, Tayob, Nabihah, DuBois, Steven G, Meyerhardt, Jeffrey A, Taplin, Mary-Ellen, Johnson, Bruce E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543498/
https://www.ncbi.nlm.nih.gov/pubmed/32959883
http://dx.doi.org/10.1093/jnci/djaa144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543498/
https://www.ncbi.nlm.nih.gov/pubmed/32959883
http://dx.doi.org/10.1093/jnci/djaa144

Ejemplares similares